Program Description:
This internet enduring material activity was developed from presentations made at the live symposium titled Diabetes, Oral Health, and Nutrition: Interrelationships, Innovations, and Interventions that took place on March 28, 2009 in Los Angeles, California.
This activity is supported through an educational grant provided by Sunstar Inc.
TARGET AUDIENCE:
This certified CME, CDE, and CE internet activity enduring material has been developed for primary care providers, dieticians, diabetes educators, dentists, periodontists, and dental hygienists who treat patients with type 2 diabetes.
TOPICS:
1. Introduction to Periodontal Diseases and Diabetes: Clinical Presentations, Etiology,
Pathogenesis, Treatment, and Prevention
2. Diabetes Complications
3. Inflammation and Systemic Diseases: Exploring New Paradigms
4. Diabetes and Periodontal Disease: The Oral-Systemic Link
5. Question and Answer Panel Session
6. Eating Habits of People with Diabetes and Impact on Oral Health
7. Interactive Panel: Practical Approaches to Prevention and Detection of Diabetes and
Periodontal Disease
STATEMENT OF NEED:
Periodontitis has been linked with worsening glycemic control in people with diabetes as well as with increased risk for diabetic complications including coronary artery disease (CAD), renal disease, and increased mortality. The incidence of periodontitis is clearly increased in poorly controlled diabetes, exacerbating the risk for atherosclerotic events associated with hyperglycemia. Inflammation is the common link between periodontal disease and diabetes. Periodontal disease allows bacteria to enter the bloodstream, activating immune cells and producing cytokines that induce insulin resistance and can impact cardiovascular health, pregnancy outcomes, and blood glucose levels. Some studies have shown that treatment of periodontitis leads to improved glycemic control, possibly by improving insulin sensitivity. Diabetes and periodontal disease are both chronic but treatable conditions requiring long-term follow-up and reinforcement for maximal treatment results, and coordinated treatment of both conditions is recommended to improve overall health. Optimal diagnosis and management of both conditions requires that primary care providers screen their patients with diabetes for periodontitis and that dentists screen their patients with periodontitis for diabetes. The goal of this symposium is to provide both types of clinicians with the information necessary to understand the connection between periodontal disease and diabetes and to develop practical screening strategies for their respective patient-care settings.
Activity Objectives:
Participants will be provided with clinically relevant, evidence-based information. Upon completion of this activity, participants should be able to:
- Identify the demographics, epidemiology, and pathophysiology of diabetes and periodontitis
- Define roles of gingivitis/periodontitis in initiating inflammatory responses, as well as the impact of hyperglycemia on oral health
- Specify the impact of periodontal disease/inflammation on risk for cardiovascular disease
- Screen high-risk individuals for diabetes and periodontitis
- Discuss relationships among nutrition, periodontal disease, and diabetes
- Explain role of diet in prevention/treatment of obesity, diabetes, and periodontal disease
|
Credits
|
Type
|
Accreditation Statement
|
Designation Statement
|
|
2.00
|
AMA PRA Category 1 Credit(s)™
|
The Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
|
The Joslin Diabetes Center designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This CME activity was planned and produced in accordance with ACCME Essentials.
|
|
2.00
|
CDE Credit
|
The University at Buffalo is accredited by the American Dental Association Continuing Education Recognition Program to provide continuing dental education for dentists and continuing education for hygienists.
|
Participants not eligible for continuing medical education credit will receive a certificate of participation.
The University at Buffalo designates this educational activity for a maximum of 2.0 CDE Credits and CE hours.
|
|
2.00
|
CE Credit
|
The University at Buffalo is accredited by the American Dental Association Continuing Education Recognition Program to provide continuing dental education for dentists and continuing education for hygienists.
|
Participants not eligible for continuing medical education credit will receive a certificate of participation.
The University at Buffalo designates this educational activity for a maximum of 2.0 CDE Credits and CE hours.
|
Faculty:
Sophia Cheung, MS, RD, CDE, LDN
Nutrition and Diabetes Educator
Asian American Diabetes Initiative
Joslin Diabetes Center
Boston, MA
Om P. Ganda, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Director, Lipid Clinic
Joslin Diabetes Center
Boston, MA
Robert J. Genco, DDS, PhD
Distinguished Professor of Oral Biology and Microbiology
Vice Provost and Director
Office of Science, Technology Transfer, and Economic Outreach
State University of New York at Buffalo
UB Technology Incubator at Baird Research Park
Amherst, NY
William C. Hsu, MD
Program Moderator
Assistant Professor of Medicine
Harvard Medical School
Director, Asian Clinic
Clinical Investigator
Joslin Diabetes Center
Boston, MA
George L. King, MD
Professor of Medicine
Harvard Medical School
Senior Vice President and Director of Research
Joslin Diabetes Center
Boston, MA
Disclosures:
Sophia Cheung has no relevant financial relationships.
Dr. Om P. Ganda is on the speakers bureau for Abbott Laboratories, GlaxoSmithKline, Kos Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer Inc, sanofi-aventis U.S. LLC, Sunstar Inc., and Takeda Pharmaceuticals North America, Inc. receives grant/research support from Eli Lilly and Company; and is a consultant and on the speakers bureau for Daiichi Sankyo, Inc.
Dr. Robert Genco receives grant/research support from Procter and Gamble, is a consultant for Colgate Palmolive Company, receives grant/research support from and is a consultant for Wm. Wrigley Jr. Company, and receives grant/research support from and is a consultant and on the speakers bureau for Sunstar Inc.
Dr. William C. Hsu is on the speakers bureau for sanofi-aventis U.S. LLC and Takeda Pharmaceuticals North America, Inc.; is a consultant and on the speakers bureau for Eli Lilly and Company and Novo Nordisk Inc.
Dr. George L. King is on the speakers bureau for Merck & Co., Inc., and receives grant/research support from Eli Lilly and Company.
Planning Committee
Dr. Richard S. Beaser, Medical Executive Director, Professional Education, Joslin Diabetes Center, is on the academic advisory board for AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Company.
Julie A. Brown, Director, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Joslin Diabetes Center does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Joslin Diabetes Center. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
The information presented in this activity is not intended to replace sound medical judgment or clinical decision-making, and the recommendations provided should be adapted to particular patient care situations, where more or less stringent interventions are necessary.
Instructions:
1. Read the learning objectives, accreditation information and faculty disclosures at the
beginning of the activity.
2. Read the text and view the slides.
3. Complete the posttest and evaluation.
4. Physicians who receive a grade of 70% or better on the posttest and who complete the
evaluation will receive immediate CME credit.
5. Dentists and dental hygienists who receive a grade of 70% or better on the posttest and who complete the evaluation will receive CDE or CE credit. Certificates will be distributed from the University of Buffalo in 4 – 6 weeks.
6. All other participants who receive a grade of 70% or better on the posttest and who
complete the evaluation will receive a certificate of participation.
For questions regarding the content of this activity, contact the accredited provider for this CME activity: cme@joslin.harvard.edu
SYSTEM REQUIREMENTS:
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.